✈️ Ann De Clercq and Liesbet Paemen are heading to Japan! 🇯🇵
13 June 2025
From June 15 to 21, 2025, they’ll represent De Clercq & Partners at Flanders’ Week during the Osaka 2025 World Expo, alongside BIOVIA and leading Flemish life sciences, healthtech and medtech companies.
They look forward to meeting our partners in Tokyo and Osaka, exploring new collaboration opportunities, and showcasing Belgian expertise at the Belgian Pavilion—one of the world’s premier innovation hubs.
Proud to be part of this international mission powered by FIT – Flanders Investment & Trade. #Osaka2025 #FlandersWeek #HealthTech #LifeSciences #BIOVIA #FIT
AI Act: Brussels Has Not Banned AI - It Has Simply Asked Us to Pay Attention
Anyone who still believes that artificial intelligence operates in a legal vacuum has probably spent the past two years somewhere without Wifi. The European AI Act is now very much with us and, since 2 August 2026, a number of its rules have become directly relevant to businesses that do not build AI systems, train foundation models or employ rooms full of data scientists. They simply use AI. In other words: almost everyone.
Anne-Lore Bex and Filip Van Lysebetten qualify as European Patent Attorneys
De Clercq & Partners is delighted to announce that Anne-lore Bex and Filip Van Lysebetten have successfully passed the European Qualifying Examination (EQE) and are now officially qualified as European Patent Attorneys.
Passing the EQE is a significant professional achievement, requiring extensive technical expertise, legal knowledge and years of dedicated preparation. As European Patent Attorneys, Anne-Lore and Filip are qualified to represent clients before the European Patent Office (EPO), providing strategic advice and guidance throughout the European patent process.
Ann De Clercq recognised in Managing IP's Top 250 Women in IP 2026
De Clercq & Partners is proud to announce that our founding partner, Dr. Ann De Clercq, has once again been recognised in Managing IP's Top 250 Women in IP 2026.
